Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1954 1
1957 1
1959 3
1961 1
1964 5
1965 4
1966 7
1967 2
1968 5
1969 4
1970 9
1971 6
1972 8
1973 10
1974 10
1975 10
1976 3
1977 6
1978 5
1979 1
1980 11
1981 2
1982 5
1983 1
1984 2
1985 8
1987 1
1988 2
1990 3
1991 6
1992 2
1993 7
1994 5
1995 3
1996 4
1997 1
1998 7
1999 8
2000 14
2001 16
2002 20
2003 26
2004 13
2005 22
2006 24
2007 26
2008 30
2009 29
2010 44
2011 39
2012 50
2013 56
2014 74
2015 84
2016 61
2017 61
2018 74
2019 90
2020 110
2021 139
2022 125
2023 122
2024 35

Text availability

Article attribute

Article type

Publication date

Search Results

1,374 results

Results by year

Filters applied: . Clear all
Page 1
Primary central nervous system lymphoma.
Ferreri AJM, Calimeri T, Cwynarski K, Dietrich J, Grommes C, Hoang-Xuan K, Hu LS, Illerhaus G, Nayak L, Ponzoni M, Batchelor TT. Ferreri AJM, et al. Nat Rev Dis Primers. 2023 Jun 15;9(1):29. doi: 10.1038/s41572-023-00439-0. Nat Rev Dis Primers. 2023. PMID: 37322012 Review.
Primary central nervous system lymphoma (PCNSL) is a diffuse large B cell lymphoma in which the brain, spinal cord, leptomeninges and/or eyes are exclusive sites of disease. ...Further research is needed to identify diagnostic biomarkers, …
Primary central nervous system lymphoma (PCNSL) is a diffuse large B cell lymphoma in which the br …
Follicular lymphoma: 2020 update on diagnosis and management.
Freedman A, Jacobsen E. Freedman A, et al. Am J Hematol. 2020 Mar;95(3):316-327. doi: 10.1002/ajh.25696. Epub 2019 Dec 22. Am J Hematol. 2020. PMID: 31814159 Free article. Review.
DISEASE OVERVIEW: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed follicular center B cells. ...Cytopenias are relatively common but constitutional symptoms of fever, night sweats, and weight loss are uncom …
DISEASE OVERVIEW: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed …
Follicular lymphoma: 2023 update on diagnosis and management.
Jacobsen E. Jacobsen E. Am J Hematol. 2022 Dec;97(12):1638-1651. doi: 10.1002/ajh.26737. Epub 2022 Oct 18. Am J Hematol. 2022. PMID: 36255040 Free article.
DISEASE OVERVIEW: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed follicular center B cells. ...Cytopenias are relatively common but constitutional symptoms of fever, night sweats, and weight loss are uncom …
DISEASE OVERVIEW: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed …
MALT lymphoma: epidemiology, clinical diagnosis and treatment.
Violeta Filip P, Cuciureanu D, Sorina Diaconu L, Maria Vladareanu A, Silvia Pop C. Violeta Filip P, et al. J Med Life. 2018 Jul-Sep;11(3):187-193. doi: 10.25122/jml-2018-0035. J Med Life. 2018. PMID: 30364585 Free PMC article. Review.
Histologically, PGL can vary from indolent marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) to aggressive diffuse large B-cell lymphoma (DLBCL). ...Long-term studies revealed that eradication …
Histologically, PGL can vary from indolent marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT …
Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment.
Liu Y, Barta SK. Liu Y, et al. Am J Hematol. 2019 May;94(5):604-616. doi: 10.1002/ajh.25460. Am J Hematol. 2019. PMID: 30859597 Free article. Review.
DISEASE OVERVIEW: Diffuse large B-cell lymphoma (DLBCL) is the most common type of aggressive non-Hodgkin lymphoma originating from the germinal center, and it represents a heterogeneous group of diseases with variable outcomes that are d …
DISEASE OVERVIEW: Diffuse large B-cell lymphoma (DLBCL) is the most common type of aggressive non-Hodgkin …
Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma.
Nastoupil LJ, Bartlett NL. Nastoupil LJ, et al. J Clin Oncol. 2023 Feb 1;41(4):903-913. doi: 10.1200/JCO.22.01848. Epub 2022 Dec 12. J Clin Oncol. 2023. PMID: 36508700 Review.
Diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, comprises a heterogenous group of morphologically, genetically, and clinically distinct diseases. ...
Diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, comprises a hetero …
Double hit and double expressors in lymphoma: Definition and treatment.
Riedell PA, Smith SM. Riedell PA, et al. Cancer. 2018 Dec 15;124(24):4622-4632. doi: 10.1002/cncr.31646. Epub 2018 Sep 25. Cancer. 2018. PMID: 30252929 Free article. Review.
Emerging biologic subsets and new prognostic markers are significantly and adversely affecting curability after standard chemoimmunotherapy for aggressive B-cell lymphomas. The identification of concurrent MYC and B-cell CLL/lymphoma 2 (BCL2) de …
Emerging biologic subsets and new prognostic markers are significantly and adversely affecting curability after standard chemoimmunotherapy …
Treatment resistance in diffuse large B-cell lymphoma.
He MY, Kridel R. He MY, et al. Leukemia. 2021 Aug;35(8):2151-2165. doi: 10.1038/s41375-021-01285-3. Epub 2021 May 20. Leukemia. 2021. PMID: 34017074 Review.
Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous disease and represents the most common subtype of lymphoma. Although 60-70% of all patients can be cured by the current standard of care in the frontline setting, the …
Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous disease and represents the most common su …
2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management.
Susanibar-Adaniya S, Barta SK. Susanibar-Adaniya S, et al. Am J Hematol. 2021 May 1;96(5):617-629. doi: 10.1002/ajh.26151. Epub 2021 Mar 19. Am J Hematol. 2021. PMID: 33661537 Free PMC article. Review.
Diffuse large B cell lymphoma (DLBCL), the most common type of Non-Hodgkin lymphoma (NHL), comprises a heterogeneous group of diseases with different biology, clinical presentations, and response to treatment. ...Studies evaluating risk-a …
Diffuse large B cell lymphoma (DLBCL), the most common type of Non-Hodgkin lymphoma (NHL), compris …
Treatment of Richter's syndrome.
Thompson PA, Siddiqi T. Thompson PA, et al. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):329-336. doi: 10.1182/hematology.2022000345. Hematology Am Soc Hematol Educ Program. 2022. PMID: 36485138 Free PMC article. Review.
Richter's syndrome (RS) is an aggressive histologic transformation of chronic lymphocytic leukemia (CLL), most commonly to diffuse large B-cell lymphoma (DLBCL). Outcomes are generally poor, with complete remission (CR) rates of only about 20% a …
Richter's syndrome (RS) is an aggressive histologic transformation of chronic lymphocytic leukemia (CLL), most commonly to diffuse …
1,374 results